Xiangxue Pharmaceutical Co.,Ltd.

SZSE:300147.SZ

5.12 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q42009 Q3
Revenue 527.686568.857571.106526.829612.628588.725441.469554.612577.269613.72734.123700.941744.584790.928577.636781,018.623797.838803658.407671.833652.959660.301610.749647.124586.078555.688514.178635.596481.855535.09512.679483.139331.181372.945339.482374.812377.366378.624398.955390.8355.601456.286351.522244.762208.544242.374215.374204.474138.798206.885180.073122.165106.967171.188154.326102.33885.532112.805101.841
Cost of Revenue 369.088365.05405.615350.285398.667354.954327.974387.449453.798475.336571.633534.683530.207554.772301.398525.63757.715494.782582.064445.977451.034426.322361.801404.532440.125384.655395.179345.129461.11340.649373.521361.966331.074207.46215.308184.048214.529225.199194.183246.348229.492218.832297.855199.962133.589111.178122.678110.181111.6773.003114.46887.96967.10557.627102.78279.36747.40241.81757.11444.85
Gross Profit 158.598203.807165.491176.544213.96233.771113.495167.164123.471138.384162.49166.258214.377236.156276.232152.37260.908303.056220.936212.429220.8226.638298.501206.216207201.423160.509169.049174.486141.206161.569150.712152.064123.721157.637155.434160.283152.167184.44152.607161.308136.769158.431151.56111.17497.366119.697105.19392.80465.79592.41792.10455.0649.3468.40674.95954.93643.71555.69156.992
Gross Profit Ratio 0.3010.3580.290.3350.3490.3970.2570.3010.2140.2250.2210.2370.2880.2990.4780.2250.2560.380.2750.3230.3290.3470.4520.3380.320.3440.2890.3290.2750.2930.3020.2940.3150.3740.4230.4580.4280.4030.4870.3830.4130.3850.3470.4310.4540.4670.4940.4880.4540.4740.4470.5110.4510.4610.40.4860.5370.5110.4940.56
Reseach & Development Expenses 18.02717.32844.95715.75211.10517.94231.28422.58526.84814.07541.26726.76310.28312.29132.7712.86111.5559.80324.31617.80211.2377.91319.083.63726.5545.35454.62211.31745.623033.288046.587045.603047.61050.762026.4031.603016.876025.6550000000000000
General & Administrative Expenses -32.85967.995-143.458177.709-36.62966.95-134.489177.044-20.56366.111-96.734151.693-13.55764.561-82.03741.239-11.84752.994-89.41849.35-21.25352.067-87.71247.154-19.62257.145-97.49149.94-20.42347.94-83.3537.861-11.93836.274-82.96337.426-26.14241.016-80.59638.626-17.61933.496-52.48930.195-11.54522.739-40.35223.53321.75917.5-33.19120.263-6.19415.064-24.53313.89912.17511.89610.22612.989
Selling & Marketing Expenses 75.29381.9891.7279.75180.28884.60770.8684.99586.54790.739160.3752.56481.43287.252100.22572.16470.79395.85797.23488.156110.49199.43999.19169.51102.49102.114100.0982.94467.2557.8371.42670.95462.25946.43366.96453.47749.37747.51867.38445.86445.0844.62150.74741.2632.35434.30344.97229.09531.23226.42236.51333.33621.01318.63619.16828.82917.70217.06621.13124.43
SG&A 42.434149.974-51.738257.4643.659151.557-63.629262.03965.984156.8563.636204.25767.875151.81318.188113.40458.945148.8517.817137.50689.238151.50711.479116.66482.868159.2592.599132.88446.827105.77-11.924108.81550.32182.707-15.99990.90323.23488.534-13.21284.4927.4678.117-1.74371.45420.80957.0414.6252.62752.99143.9223.32253.59914.8233.7-5.36442.72829.87728.96231.35737.419
Other Expenses -21.821-9.655-28.391-10.274-10.923-9.219181.983-101.23196.726-4.657-26.899-18.2697.842-3.465-50.667-2.897-7.491-1.899-4.1117.952-0.1690.834-63.9981.21428.14720.615-43.48636.882-5.44132.39430.73118.4363.2793.37522.3035.7582.9550.9381.1179.9522.0684.54210.5460.9816.203-0.4082.411-1.2170.6022.0150.684-0.8693.5890.1481.462-0.274-0.1470.166-0.5991.281
Operating Expenses 121.57165.584166.584168.494157.382160.28149.639183.394189.558166.268288.518135.542146.99163.137196.049118.607155.854157.765185.559155.818171.496151.465180.371114.819166.674157.649151.835127.196101.928109.993136.771111.725119.99385.564116.34694.43888.39491.195118.51187.47689.43580.20888.24773.81563.33258.69281.98653.75554.44545.11459.63355.33336.30934.31934.73343.97130.88529.36832.63538.205
Operating Income -67.553-16.678-233.184-58.826-55.86415.159-233.96-16.23-66.087-24.279-665.751-11.44451.26137.22629.02523.08587.21689.922-6.13644.27326.37548.05741.74956.41613.87113.98928.27227.65747.122.501-26.89116.39334.42535.28224.34454.25160.05846.91147.07357.31260.4142.14653.65763.2235.15725.29931.60744.75233.18816.14230.5234.15617.38515.13228.74427.17119.68611.24418.59315.343
Operating Income Ratio -0.128-0.029-0.408-0.112-0.0910.026-0.53-0.029-0.114-0.04-0.907-0.0160.0690.0470.050.0340.0860.113-0.0080.0670.0390.0740.0630.0920.0210.0240.0510.0540.0740.005-0.050.0320.0710.1070.0650.160.160.1240.1240.1440.1550.1190.1180.180.1440.1210.130.2080.1620.1160.1480.190.1420.1410.1680.1760.1920.1310.1650.151
Total Other Income Expenses Net -21.821-9.655-28.391-10.289-10.909-6.646-10.106-107.032-38.759-18.263-33.173-6.794-3.633-3.465-50.824-2.897-7.491-1.899-4.1117.952-0.1690.834-63.9981.21428.14720.615-43.48636.882-5.44132.39430.318.4363.2793.37522.2875.7582.9550.9381.0929.9522.0684.54210.5460.9816.203-0.4082.411-1.2170.6022.0150.684-0.8693.5890.1481.462-0.274-0.1470.166-0.5991.281
Income Before Tax -89.374-26.333-261.575-69.115-66.7738.513-244.066-123.262-104.846-42.542-698.925-18.23947.62833.76-21.79920.18979.72588.024-10.24652.22626.20648.891-22.24957.6342.01934.604-15.21464.53941.67834.8953.40934.82937.70438.65746.63160.00963.01347.84948.16667.26462.47746.68864.20464.20141.3624.89134.01843.53533.7918.15731.20433.28720.97415.28130.20626.89719.53911.4117.99516.624
Income Before Tax Ratio -0.169-0.046-0.458-0.131-0.1090.014-0.553-0.222-0.182-0.069-0.952-0.0260.0640.043-0.0380.030.0780.11-0.0130.0790.0390.075-0.0340.0940.0650.059-0.0270.1260.0660.0720.0060.0680.0780.1170.1250.1770.1680.1270.1270.1690.160.1310.1410.1830.1690.1190.140.2020.1650.1310.1510.1850.1720.1430.1760.1740.1910.1330.160.163
Income Tax Expense 2.8752.2978.284.385-0.1010.231-10.069-2.716.625-0.6427.5076.8497.0341.53216.45-2.1773.8396.231.546-1.041-14.9275.3697.99.0523.1343.947-12.61121.0571.7493.5797.3164.3582.52.7886.171.9173.0864.682-0.6521.1232.6324.9476.8696.2186.6043.8736.9365.0135.3293.0495.6294.9672.7252.5463.7373.9423.1441.8132.3292.668
Net Income -99.561-35.66-242.891-80.08-70.538.282-233.997-120.552-111.471-41.9-705.364-33.41325.68424.623-49.4666.74960.36780.77-15.67736.28924.97230.931-35.44938.08327.78526.02-4.44921.80626.05622.526-10.75923.57521.68631.52232.20952.01954.41138.65945.03762.06453.99935.69650.91752.09133.9721.26427.1537.37827.77514.86525.55427.62117.37512.94626.02922.65716.0499.46415.5113.644
Net Income Ratio -0.189-0.063-0.425-0.152-0.1150.014-0.53-0.217-0.193-0.068-0.961-0.0480.0340.031-0.0860.010.0590.101-0.020.0550.0370.047-0.0540.0620.0430.044-0.0080.0420.0410.047-0.020.0460.0450.0950.0860.1530.1450.1020.1190.1560.1380.10.1120.1480.1390.1020.1120.1740.1360.1070.1240.1530.1420.1210.1520.1470.1570.1110.1370.134
EPS -0.15-0.05-0.38-0.12-0.110.013-0.36-0.18-0.18-0.063-1.07-0.0540.0420.04-0.0810.010.0890.12-0.0230.050.0340.05-0.0570.060.0440.04-0.0070.030.0390.03-0.0160.0360.0330.0480.0510.0760.0840.060.0770.120.0870.0580.0820.0830.0540.0320.0440.0640.0470.0250.0420.0440.0280.020.0450.0490.0350.020.0330.035
EPS Diluted -0.15-0.05-0.38-0.12-0.110.013-0.36-0.18-0.17-0.063-1.06-0.0540.0420.04-0.080.010.0890.12-0.0230.050.0340.05-0.0570.060.0440.04-0.0070.030.0390.03-0.0160.0360.0330.0480.0510.0760.0840.060.0770.120.0870.0580.0820.0830.0540.0320.0440.0640.0440.0250.0420.0440.0280.020.0450.0490.0350.020.0330.035
EBITDA 9.90626.987-78.426-6.03744.69665.506-43.492-37.675-95.95324.185-114.1335.80177.00166.31762.72429.77599.656139.532.31494.25856.52992.11253.896104.37113.38952.621178.21429.439105.80336.84393.5844.26345.75335.91688.89369.25885.15661.141108.69765.48886.27556.871105.06577.87665.64638.8458.57651.43938.59220.88849.34136.7728.68415.02135.48530.98823.59314.34721.87818.786
EBITDA Ratio 0.0190.047-0.137-0.0110.0730.111-0.099-0.068-0.1660.039-0.1550.0080.1030.0840.1090.0440.0980.1750.040.1430.0840.1410.0820.1710.1750.090.3210.0570.1660.0760.1750.0860.0950.1080.2380.2040.2270.1620.2870.1640.2210.160.230.2220.2680.1860.2420.2390.1890.150.2380.2040.2350.140.2070.2010.2310.1680.1940.184